Diagnostic Technologies: Page 88

CDC awards Chembio $3.2M for development of syphilis POC test

By LabPulse.com staff writers

Under the contract, Chembio will develop a syphilis test and confirm assay based on its Dual Path Platform (DPP) technology and DPP Micro Reader II. The assay will be designed to simultaneously and separately detect treponemal and nontreponemal IgM and IgG antibodies.

September 5, 2022

Video telemed diagnoses are accurate: Mayo Clinic study

By Dexter Johnson

In a 90-day period from late March to late June 2020, nearly 2400 patients who underwent a video telemedicine consultation had their diagnosis match an in-person reference standard diagnosis in 86.9% of cases.

September 5, 2022

Cue Health requests FDA de novo clearance for at-home flu test

By LabPulse.com staff writers

Clearance would permit the test to be used at home and elsewhere at the point-of-care (POC).

September 1, 2022

Sectra posts higher Q1 sales as profitability dips

By LabPulse.com staff writers

During the quarter, Sectra reported revenue of 484.1 million Swedish krona ($44.8 million), an increase of 19.7% compared with 405.7 million Swedish krona ($37.6 million) after adjusting for currency fluctuations. At unadjusted currency rates, revenues grew 10.7%.

September 1, 2022

Nanomix, Mobility to develop COVID-19 antibody POC test

By LabPulse.com staff writers

Under the agreement, Nanomix would supply the product elements and Mobility Health would complete development and validation of the test.

September 1, 2022

Interpace announces validation data for thyroid cancer test

By LabPulse.com staff writers

The company said the most recent data shows that the addition of microRNA pairwise expression profiling on its ThyraMIRv2 assay provides clinically and statistically superior risk stratification of indeterminate thyroid nodules by the original ThyraMIR assay.

September 1, 2022

Can monkeypox be asymptomatic?

By Leo O'Connor

A Belgian study published in Nature Medicine, which included 224 patient samples, discovered that three of four men with positive monkeypox virus test results reported that they were asymptomatic at the time of testing.

September 1, 2022

AACC on POC tests for fertility, reproductive health

By LabPulse.com staff writers

The guidance is intended to ensure that patients and their babies fully benefit from such testing, AACC said.

August 31, 2022

Elevated cfDNA levels linked to severity of PAH

By LabPulse.com staff writers

The new blood test measures DNA fragments shed by damaged cells; according to the NIH, the test could also be used to predict survivability.

August 31, 2022

Avails Medical nabs $1.7M to develop AST test

By LabPulse.com staff writers

The money will be used to further develop the fully electrical Avails Medical eAST system, which provides a time-to-results average of five hours. The system will enable healthcare providers to determine the most effective antibiotic treatment for patients with severe bloodstream infections, such as sepsis, particularly those involving multidrug-resistant pathogens.

August 31, 2022

Agilent, Mettler Toledo collaborate on chromatography

By LabPulse.com staff writers

The firms have introduced a new sample preparation workflow that improves results and provides a "digital experience for operating chromatographic instruments," Jacob Thaysen, president of Agilent's Life Sciences and Applied Markets Group, said in a statement.

August 31, 2022

NfL IDs patients predisposed to neurotoxic complications

By LabPulse.com staff writers

Analyzing blood samples from patients before, during, and after CAR-T cell therapy, Washington University School of Medicine researchers found that levels of neurofilament light chain (NfL) proteins are higher in patients who develop neurotoxic complications.

August 31, 2022

Previous Page

Page 88 of 293

Next Page